Background: Clinical chemistry testing is influenced by a variety of preanalytical variables, including sample preparation. The presence of a diluted plasma layer at the top of primary tubes containing plasma citrate has recently been reported. However, no indication is available so far on the potential non-homogeneous distribution of clinical chemistry analytes during centrifugation of primary tubes containing lithium-heparin as an additive. Methods: A total of 40 lithium-heparin plasma samples were collected from volunteers and immediately centrifuged. An aliquot was obtained from the upper 0.4 mL of plasma (upper aliquot), 1.0 mL of plasma was discarded, and a second aliquot (lower aliquot) was obtained from the remaining plasma. The concentrations of alanine aminotransferase, albumin, alkaline phosphatase, amylase, amylase pancreatic, aspartate aminotransferase, direct bilirubin, total bilirubin, blood urea nitrogen, calcium, chloride, cholesterol, C-reactive protein (CRP), creatinine, creatine kinase, g-glutamyltransferase (GGT), glucose, highdensity lipoprotein-cholesterol, iron, lactate dehydrogenase (LDH), magnesium, phosphate, potassium, total protein, sodium, triglycerides and uric acid were assayed on a Roche/Hitachi Modular System P according to the manufacturer's specifications and using proprietary reagents. Sodium, chloride and potassium were measured on a Roche/Hitachi Modular System using indirect ion-selective electrode methods. Results: We observed a statistically significant difference between the upper and lower aliquots for CRP (3.88"0.67 vs. 3.94"0.68 mg/L; ps0.025), GGT (32.1"8.0 vs. 31.8"8.0 U/L; ps0.013), LDH (395"19 
vs. 386"20 U/L; ps0.010) and triglycerides (1.29"0.09 vs. 1.27"0.09 mmol/L; ps0.001); results for the other analytes were not significantly different. In no case did the mean percentage bias recorded between aliquots exceed the current analytical quality specifications for desirable bias.
Conclusions:
The results of our investigation show that plasma layer stratification might occur in primary lithium-heparin tubes for a limited number of routine clinical chemistry tests, introducing a statistically significant bias in the measurement of GGT, LDH, triglycerides and CRP in the upper vs. the bottom section. When delayed testing is necessary for these parameters, we suggest that plasma should be separated after centrifugation and appropriately mixed before delayed/repeated analysis or aliquoting. Clin Chem Lab Med 2008;46:1180-2.
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In the context of total quality management and according to a long-standing tradition of analytical quality control programs, clinical laboratories are adopting new approaches to assess and continuously improve the total quality of their services (1). Analytical quality remains an essential characteristic of any laboratory test and quality specifications should be available for each and every laboratory procedure, especially for precision and bias (1) . However, in today's laboratories, increased efficiency and productivity are of pivotal importance. Equally important is the ability to automate analysis processes without sacrificing sample integrity or data quality. The aim of laboratory automation is to improve the quality and efficiency of all laboratory operations, and may provide a solution to the quality demands and staff shortages faced by clinical laboratories. Currently, automation involves both the analytical phase and preanalytical steps, and routine clinical chemistry testing is strongly influenced by a variety of preanalytical variables (2, 3) . Among these variables, sample preparation is crucial for several areas of testing (4) and specific recommendations are endorsed by the Clinical and Laboratory Standards Institute (CLSI), containing detailed procedures for the collection, transportation, processing and storage of blood specimens for clinical chemistry testing (5) . Several automated preanalytical systems are capable of providing labelled aliquots for offline testing. Most aliquoters can perform clot detection and level sensing. Moreover, automated clinical chemistry analyzers have a sample needle with capacitive liquid-level sensing on the primary testing tube. However, no clear indication is available so far on the potential non-homogeneous distribution of clinical chemistry analytes during centrifugation of primary lithium-heparin tubes and on the optimal depth of plasma sampling.
Recently, Redaelli et al. (6) observed falsely prolonged up to incoagulable prothrombin time results in citrated plasma from patients on oral anticoagulant therapy, which they attributed to the presence of a diluted plasma layer at the top of the primary tubes. Moreover, the authors found that the top plasma contained lower concentrations of coagulation factors, proteins and lipids by measuring these in top and bottom aliquots. These data indicate that a diluted plasma layer might be present at the top of primary tubes after centrifugation of citrated plasma. However, there is no reliable evidence that a similar phenomenon might also occur after centrifugation of primary sample tubes referred for routine clinical chemistry testing and containing lithium-heparin as an additive.
For 40 healthy volunteers recruited among hospital personnel, whole blood was directly collected into 3.5-mL vacuum tubes containing gel and lithium heparin (Terumo Europe, Haasrode, Belgium) using a 20G Venoject ᮋ multi-sample straight needle (Terumo Europe, Leuven, Belgium) by a single experienced phlebotomist. Venipunctures were performed in the morning of the same day on fasting patients, who gave explicit informed consent for the investigation. All phases of sample collection were accurately standardized, including identical time for tourniquet placement (-20 s), and the use of tubes and reagents of the same lot or batch. No specimen needed to be discarded due to unsatisfactory attempts, difficulty in locating easy venous accesses, vein missing, manifest hemolysis or lipemia. Immediately after collection, the tubes were gently mixed five times and centrifuged at 1500=g for 10 min at room temperature, as recommend by CLSI. The plasma was separated into two aliquots in Roche Modular assay cups (Roche Diagnostics GmbH, Mannheim, Germany), as follows: a first aliquot was obtained from the upper 0.4 mL of plasma (upper aliquot), 1.0 mL of plasma was discarded, and a second aliquot (lower aliquot) was obtained from the remaining plasma in the primary tube (0.4-0.7 mL, depending on the plasma volume left). Only the upper and lower aliquots were tested to emphasize differences due to potential nonhomogeneous separation of lithium-heparin plasma. The concentrations of alanine aminotransferase, albumin, alkaline phosphatase, amylase, amylase pancreatic, aspartate aminotransferase, direct bilirubin, total bilirubin, blood urea nitrogen, calcium, chloride, cholesterol, C-reactive protein (CRP), creatinine, creatine kinase, g-glutamyltransferase (GGT), glucose, highdensity lipoprotein-cholesterol (HDL-C), iron, lactate dehydrogenase (LDH), magnesium, phosphate, potassium, total protein, sodium, triglycerides and uric acid were assayed on a Roche/Hitachi Modular System P (Roche Diagnostics GmbH) according to the manufacturer's specifications and using proprietary reagents. Sodium, chloride and potassium were measured on a Roche/Hitachi Modular System using indirect ionselective electrode methods. Total imprecision, as expressed by the coefficient of variation (CV), was less than 2.5% for all analytes tested. All measurements were performed in duplicate within a single analytical session and results were averaged. Results are expressed as geometric mean"standard error of the mean. The significance of differences was assessed using a Wilcoxon matched-pairs signed ranks test; the level of statistical significance was set at p-0.05. Bland-Altman analysis was used to evaluate the differences between the aliquots, which are reported as geometric mean"SEM for the percentage bias between the lower and upper aliquots.
We observed a statistically significant difference between the upper and lower aliquots for CRP (Table 1) . However, in no case did the mean percentage bias recorded between aliquots exceed the current analytical quality specifications for desirable bias (Table 1 ) (7).
The results of our investigation show that plasma layer stratification might occur in primary lithiumheparin tubes for a limited number of routine clinical chemistry tests, introducing a statistically significant bias in the measurement of GGT, LDH, triglycerides and CRP in the bottom vs. the top section. However, such differences were within the analytical quality specifications for desirable bias (7), indicating that they might be analytically but not clinically meaningful. Nevertheless, we believe that this bias should be recognized and listed among the potential sources of preanalytical variability in routine laboratory practice (2, 3, 8) , especially when preparation of multiple aliquots from an original primary collection tube is required for storage and delayed analysis of samples. For epidemiological studies and long-term follow up, it is also pivotal to establish to what extent the observed variation for a certain analyte can be attributed to analytical or biological variability. In such cases, we suggest that plasma should be separated from the pellet immediately after centrifugation and appropriately mixed before delayed/repeated analysis or aliquoting. To guarantee reproducible results, we also suggest that the capacitive liquid-level sensing of analyzers should be fixed at a standardized depth and regularly checked, which would allow plasma collection from the same plasma layer in primary tubes.
Except for triglycerides (triglyceride-rich lipoproteins, the so-called floating b-lipoprotein), which tend to accumulate in the top fraction of plasma owing to their specific hydrated density and flotation rates (9), definitive cause(s) and mechanisms of the observed non-homogeneous separation of GGT, LDH and CRP in plasma from primary collection tubes containing Results are expressed as geometric mean"standard error of the mean. Differences between the upper and lower aliquots were evaluated using a Wilcoxon matched-pairs signed ranks test. The percentage bias for the lower vs. upper aliquot is compared with the current analytical quality specifications for desirable bias derived from biological variation (6).
lithium heparin could not be definitively established. It has been reported that hypertriglyceridemia may increase the volume displacement effect of lipoproteins (10), which would explain in part the lower results for low-molecular-weight proteins in the upper layer. However, in no case did the results for the four samples with triglycerides )2.0 mmol/L (one )4 mmol/L) deviate from those reported for the group of subjects with triglycerides -2.0 mmol/L. Therefore, further studies should be planned to assess whether our results can be reproduced using different types of tubes and sample matrix (serum) (11) , and whether intrinsic characteristics of the specimen (dysproteinemia), tube type and geometry, degree of negative pressure, and plasma-anticoagulant interactions play a role in generating this intriguing phenomenon.
